Tinostamustine clinical trials
Also written EDO-S101.
How each study uses tinostamustine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the tinostamustine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 3
Mundipharma Research Limited (3) · M.D. Anderson Cancer Center (1) · Global Coalition for Adaptive Research (1) · Mundipharma-EDO GmbH (1) · Markus Joerger (1)
Often tested with
Tested in the same studies.
Regorafenib (1) · GDC-0084 (1) · Dianhydrogalactitol (1) · TSP-1 Activator VT1021 (1) · Troriluzole (1) · Pegargiminase (1) · AZD1390 (1)
Related medicines
As reviewed, each with the page that says it.
- One of HDAC inhibitors source
Studies
Open first, then newest update. How each study uses tinostamustine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaRecruitingPhase 2/3Global Coalition for Adaptive ResearchNCT03970447Written as Tinostamustine
- Study of Tinostamustine for Adjuvant Treatment of GlioblastomaCompletedEarly Phase 1Mundipharma Research LimitedNCT05432375Written as Tinostamustine
- Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated GlioblastomaCompletedPhase 1M.D. Anderson Cancer CenterNCT03452930Written as Tinostamustine
- Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.CompletedPhase 1/2Mundipharma Research LimitedNCT03345485Written as Tinostamustine 60mg/m2 over 30min
- Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic MalignanciesCompletedPhase 1Mundipharma Research LimitedNCT02576496Written as Tinostamustine
- Tinostamustine Conditioning and Autologous Stem CellTerminatedPhase 1/2Mundipharma-EDO GmbHNCT03687125Written as Tinostamustine
- Tinostamustine and Nivolumab in Advanced MelanomaStatus unknownPhase 1Markus JoergerNCT03903458Written as Tinostamustine
Codes
What other systems call tinostamustine · ClinicalTrials.gg INT000521
- MeSH (NLM) C000609929tinostamustineConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 29DKI2H2NYTINOSTAMUSTINEConfirmed FDA, NLM
- NCI Thesaurus C126105TinostamustineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000609929 | tinostamustine | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 29DKI2H2NY | TINOSTAMUSTINE | Confirmed FDA, NLM |
| NCI Thesaurus | C126105 | Tinostamustine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.